Luigino Calzetta received a PhD in Pharmacology at King’s College London (UK), where he is an Honorary Researcher Fellow at the Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science. He is professor of Respiratory Medicine at the Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy. 
His research interests include the pharmacotherapy of chronic obstructive respiratory disorders such as human and equine asthma and COPD, with studies spanning from basic pharmacology to clinical trials. He has pharmacologically characterized innovative agents for the treatment of respiratory diseases, identified novel mechanisms and pathways modulating the airway contractility, investigated the pharmacological interaction between bronchodilators and anti-inflammatory drugs, and validated ex vivo models of airway hyperresponsiveness. He is also interested in high-quality quantitative syntheses of interventional pharmacological trials and carried out large epidemiological studies on the relationship between pharmacotherapy, respiratory diseases, and comorbidities, mainly metabolic and cardiovascular disorders.
Luigino Calzetta has published more than 200 peer-review papers and written monographs on asthma, COPD and related topics. He is in the top 10 most highly cited researchers in the world on bronchodilator agents, and received the Chest Young Researchers Award